FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Pollak

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Case Control Studies

Physiology

Premenopause

Disorders

Geographic Areas

United States

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Ying Bao; Julie E Buring; Barbara B Cochrane; Charles S Fuchs; John Michael Gaziano; Edward L Giovannucci; Virginia Kaklamani; Peter Kraft; I-Min Lee; Jennifer H Lin; Jing Ma; JoAnn E Manson; Shuji Ogino; Michael N Pollak; Nader Rifai; Howard D Sesso; Meir J Stampfer; Brian M Wolpin
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Shiva Javeshghani; Shane Austin; Miguel Bazile; Marie-José Blouin; Julie St-Pierre; Ivan Topisirovic; Mahvash Zakikhani; Michael N Pollak
Carbon source and myc expression influence the antiproliferative actions of metformin.
Mahvash Zakikhani; Daina Avizonis; Miguel Bazile; Sina Hashemi; Shiva Javeshghani; Julie St Pierre; Michael N Pollak
Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Pollak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ying Bao; Julie E Buring; Barbara B Cochrane; Charles S Fuchs; John Michael Gaziano; Edward L Giovannucci; Virginia Kaklamani; Peter Kraft; I-Min Lee; Jennifer H Lin; Jing Ma; JoAnn E Manson; Shuji Ogino; Michael N Pollak; Nader Rifai; Howard D Sesso; Meir J Stampfer; Brian M Wolpin
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Journal of the National Cancer Institute 2013;105(2):95-103.
2012: Shiva Javeshghani; Shane Austin; Miguel Bazile; Marie-José Blouin; Julie St-Pierre; Ivan Topisirovic; Mahvash Zakikhani; Michael N Pollak
Carbon source and myc expression influence the antiproliferative actions of metformin.
Cancer research 2012;72(23):6257-67.
2012: Mahvash Zakikhani; Daina Avizonis; Miguel Bazile; Sina Hashemi; Shiva Javeshghani; Julie St Pierre; Michael N Pollak
Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
PloS one 2012;7(11):e49513.
2012: Megan S Rice; Bernard Rosner; Dejun Shen; Rulla M Tamimi; Laura C Collins; James L Connolly; Susan E Hankinson; Michael N Pollak; Shelley S Tworoger
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.
Breast cancer research : BCR 2012;14(2):R44.
2011: Kimmie Ng; Daniel J Sargent; Richard M Goldberg; Jeffrey A Meyerhardt; Erin M Green; Henry C Pitot; Bruce W Hollis; Michael N Pollak; Charles S Fuchs
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1599-606.
2011: Katharina Nimptsch; Elizabeth A Platz; Michael N Pollak; Stacey A Kenfield; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.
International journal of cancer. Journal international du cancer 2011;128(3):660-7.
2010: Mahvash Zakikhani; Marie-José Blouin; Esther Piura; Michael N Pollak
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells.
Breast cancer research and treatment 2010;123(1):271-9.
2010: Lorelei A Mucci; Jennifer R Stark; Michael N Pollak; Haojie Li; Tobias Kurth; Meir J Stampfer; Jing Ma
Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):484-91.
2010: Olivia I Okereke; Tobias Kurth; Michael N Pollak; J Michael Gaziano; Francine Grodstein
Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II.
Neuroepidemiology 2010;34(4):200-7.
2010: Xuefen Su; GRaham Colditz; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Michael N Pollak; Bernard Rosner; Rulla M Tamimi
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
International journal of cancer. Journal international du cancer 2010;126(1):180-90.
2009: Brian M Wolpin; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Kana Wu; Michael N Pollak; Edward L Giovannucci; Charlie S Fuchs
Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):176-85.
2008: Mahvash Zakikhani; Ryan J O Dowling; Nahum Sonenberg; Michael N Pollak
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
Cancer prevention research (Philadelphia, Pa.) 2008;1(5):369-75.
2008: Jocelyn S Kasper; Yan Liu; Michael N Pollak; Nader Rifai; Edward Giovannucci
Hormonal profile of diabetic men and the potential link to prostate cancer.
Cancer causes & control : CCC 2008;19(7):703-10.
2008: Olivia I Okereke; Michael N Pollak; Frank B Hu; Susan E Hankinson; Dennis J Selkoe; Francine Grodstein
Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes.
Psychoneuroendocrinology 2008;33(4):455-61.
2007: Rana Singh; Gagan Deep; Marie-José Blouin; Michael N Pollak; Rajesh Agarwal
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Carcinogenesis 2007;28(12):2567-74.
2007: Komal Raina; Marie-José Blouin; Rana Singh; Noreen Majeed; Gagan Deep; Leyon Varghese; L Michael Glodé; Norman M Greenberg; David Hwang; Pinchas Cohen; Michael N Pollak; Rajesh Agarwal
Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Cancer research 2007;67(22):11083-91.
2007: Dominique S Michaud; Brian M Wolpin; Ed Giovannucci; Simin Liu; Barbara Cochrane; JoAnn E Manson; Michael N Pollak; Jing Ma; Charlie S Fuchs
Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):2101-9.
2007: Eva S Schernhammer; Shelley S Tworoger; A Heather Eliassen; Stacey A Missmer; Jeff M Holly; Michael N Pollak; Susan E Hankinson
Body shape throughout life and correlations with IGFs and GH.
Endocrine-related cancer 2007;14(3):721-32.
2007: Brian M Wolpin; Dominique S Michaud; Edward L Giovannucci; Eva S Schernhammer; Meir J Stampfer; JoAnn E Manson; Barbara Cochrane; Thomas E Rohan; Jing Ma; Michael N Pollak; Charlie S Fuchs
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Cancer research 2007;67(16):7923-8.
2007: Shelley S Tworoger; I-Min Lee; Julie E Buring; Michael N Pollak; Susan E Hankinson
Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(8):1691-5.
2007: Brian M Wolpin; Dominique S Michaud; Edward L Giovannucci; Eva S Schernhammer; Meir J Stampfer; JoAnn E Manson; Barbara Cochrane; Thomas E Rohan; Jing Ma; Michael N Pollak; Charlie S Fuchs
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
British journal of cancer 2007;97(1):98-104.
2007: Andrea Schaffer; Anita Koushik; Helen Trottier; Eliane Duarte; Nabil Mansour; Jocelyne Arseneau; Diane Provencher; Lucy Gilbert; Walter H Gotlieb; Alex Ferenczy; François Coutlée; Michael N Pollak; Eduardo L Franco
Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):716-22.
2007: Rulla M Tamimi; David G Cox; Peter Kraft; Michael N Pollak; Christopher A Haiman; Iona Cheng; Matthew L Freedman; Susan E Hankinson; David J Hunter; GRaham Colditz
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
Breast cancer research : BCR 2007;9(1):R18.
2007: A Heather Eliassen; Shelley S Tworoger; Christos S Mantzoros; Michael N Pollak; Susan E Hankinson
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):161-4.
2006: Eva S Schernhammer; Jeff M Holly; David J Hunter; Michael N Pollak; Susan E Hankinson
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Endocrine-related cancer 2006;13(2):583-92.
2006: Stacey A Missmer; Donna Spiegelman; Elizabeth R Bertone-Johnson; Robert L Barbieri; Michael N Pollak; Susan E Hankinson
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):972-8.
2006: Esther K Wei; Jing Ma; Michael N Pollak; Nader Rifai; Charlie S Fuchs; Susan E Hankinson; Edward Giovannucci
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(4):750-5.
2006: Walter H Gotlieb; Ilan Bruchim; Jing Gu; Ying Shi; Anne Camirand; Marie-José Blouin; Yunhua Zhao; Michael N Pollak
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
Gynecologic oncology 2006;100(2):389-96.
2005: Simone P Pinheiro; Michelle D Holmes; Michael N Pollak; Robert L Barbieri; Susan E Hankinson
Racial differences in premenopausal endogenous hormones.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(9):2147-53.
2005: Esther K Wei; Jing Ma; Michael N Pollak; Nader Rifai; Charlie S Fuchs; Susan E Hankinson; Edward Giovannucci
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):850-5.
2005: Eva S Schernhammer; Jeff M Holly; Michael N Pollak; Susan E Hankinson
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(3):699-704.
2004: Michael N Pollak; Eva S Schernhammer; Susan E Hankinson
Insulin-like growth factors and neoplasia.
Nature reviews. Cancer 2004;4(7):505-18.
2004: Michael N Pollak
Insulin-like growth factors and neoplasia.
Novartis Foundation symposium 2004;262():84-98; discussion 98-107, 265-8.
2003: Eva S Schernhammer; Susan E Hankinson; David J Hunter; Marie-José Blouin; Michael N Pollak
Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk.
International journal of cancer. Journal international du cancer 2003;107(1):60-4.
2003: Michael N Pollak; William D Foulkes
Challenges to cancer control by screening.
Nature reviews. Cancer 2003;3(4):297-303.
2002: Edward Giovannucci; Christopher A Haiman; Elizabeth A Platz; Susan E Hankinson; Michael N Pollak; David J Hunter
Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1509-10.
2002: Michelle D Holmes; Michael N Pollak; Susan E Hankinson
Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(9):862-7.
2002: Michelle D Holmes; Michael N Pollak; Walter C Willett; Susan E Hankinson
Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(9):852-61.
2002: Stacey A Missmer; Christopher A Haiman; David J Hunter; Walter C Willett; GRaham Colditz; Frank E Speizer; Michael N Pollak; Susan E Hankinson
A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
International journal of cancer. Journal international du cancer 2002;100(3):332-6.
2000: Elizabeth A Platz; Michael N Pollak; Walter C Willett; Edward Giovannucci
Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3.
Journal of the American Academy of Dermatology 2000;42(6):1003-7.
2000: Edward Giovannucci; Michael N Pollak; Elizabeth A Platz; Walter C Willett; Meir J Stampfer; Noreen Majeed; GRaham Colditz; Frank E Speizer; Susan E Hankinson
A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(4):345-9.
1999: Elizabeth A Platz; Michael N Pollak; Eric B Rimm; Noreen Majeed; Y Tao; Walter C Willett; Edward Giovannucci
Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(12):1107-10.
1999: J Ma; Michael N Pollak; Edward Giovannucci; J M Chan; Y Tao; Charles H Hennekens; Meir J Stampfer
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Journal of the National Cancer Institute 1999;91(7):620-5.